Mitochondria are not only the 'powerhouse' of the cell; they are also involved in a multitude of processes that include calcium storage, the cell cycle and cell death. traditional means of investigating mitochondrial importance in a given cellular process have centered upon depletion of mtDna through chemical or genetic means. although these methods severely disrupt the mitochondrial electron transport chain, mtDna-depleted cells still maintain mitochondria and many mitochondrial functions. Here we describe a straightforward protocol to generate mammalian cell populations with low to nondetectable levels of mitochondria. ectopic expression of the ubiquitin e3 ligase parkin, combined with short-term mitochondrial uncoupler treatment, stimulates widespread mitophagy and effectively eliminates mitochondria. In this protocol, we explain how to generate parkin-expressing, mitochondriadepleted cells from scratch in 23 d, as well as offer a variety of methods for confirming mitochondrial clearance. Furthermore, we describe culture conditions to maintain mitochondrial-depleted cells for up to 30 d with minimal loss of viability, for longitudinal studies. this method should prove useful for investigating the importance of mitochondria in a variety of biological processes.
IntroDuctIon
Mitochondria have traditionally been viewed as the powerhouse of the cell because of their central role in metabolism and energy production. More recently, mitochondria have been implicated in a wide variety of other cellular roles, including calcium storage, migration, cell death, senescence and inflammation 1 . Equally, impairment of mitochondrial homeostasis has been strongly linked to a wide range of diseases 2, 3 ; for this reason, understanding the mechanisms that regulate mitochondrial health is of fundamental importance. To this end, eukaryotic cells are equipped with a range of mitochondrial quality control (QC) mechanisms 4, 5 .
Mitochondria-specific autophagy, hereafter termed 'mitophagy' , is a key mitochondrial QC mechanism that helps maintain mitochondrial fitness by efficiently removing dysfunctional organelles. Although several different mechanisms regulating mitophagy have been described in mammalian cells, the best understood is PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy 6 . In this process, mitophagy occurs primarily following a complex interplay between the Ser/Thr kinase PINK1 and the E3 ubiquitin ligase Parkin 4 . In healthy mitochondria, PINK1 is subject to constant turnover; cleavage of its mitochondrial targeting sequence by the mitochondria intermembrane space protease PARL reveals a destabilizing N-terminal residue that targets PINK1 for proteasomal degradation 7, 8 . Disruption of mitochondrial function causes an accumulation of PINK1 on the mitochondrial outer membrane, where it phosphorylates ubiquitin and Parkin, leading to the activation of the Parkin E3 ubiquitin ligase at the mitochondria [9] [10] [11] . Parkin recruitment to mitochondria requires mitofusin 2 in some settings 12, 13 , but it is dispensable in others 14 . In a feed-forward mechanism, Parkin ubiquitinates mitochondrial substrates, which, in turn, leads to more PINK1 substrate phosphorylation and Parkin activity. Ubiquitinated mitochondria are targeted for autophagy following recognition by specific ubiquitin-binding adaptor proteins 9 . Importantly, experimentally induced PINK1/Parkin-mediated mitophagy can reduce mitochondrial levels to below the level of detection, thereby opening its use as an experimental tool to study mitochondrial function 15, 16 .
Development of an assay that allows the generation of mitochondria-depleted cells
A well-established approach to studying mitochondrial function in various processes centers upon depletion of mtDNA to generate so-called ρ 0 cells 17 . Typically, this is achieved by longterm culture in the presence of ethidium bromide (EtBr), which inhibits replication of mitochondrial, but not nuclear, DNA. Nevertheless, this method has various drawbacks, including the extended time (typically weeks) required to generate ρ 0 cells and potential unwanted mutagenic effects on genomic DNA caused by EtBr treatment. Alternative methods of depleting mtDNA and generating ρ 0 cells include mitochondrial targeting of the restriction endonuclease EcoRI 18 and expression of a dominant negative form of Polγ (POLG), a gene that codes for the catalytic subunit of the mtDNA polymerase 19 . However, these solutions do not circumvent a major drawback, which is that ρ 0 cells still contain functional mitochondria. For example, mitochondrial apoptosis proceeds efficiently in ρ 0 cells 20 . This prompted us to further develop a method to remove mitochondria, thus allowing the study of cellular functions in the absence of all aspects of mitochondrial biology.
Herein, we describe a facile protocol that exploits PINK1/ Parkin-mediated mitophagy as a tool for investigating mitochondrial function. In short, the method entails overexpression of Parkin and short-term mitochondrial depolarization to stimulate widespread mitophagy. This generates mammalian cells with low to nondetectable mitochondrial content, allowing comparison of matched cells proficient or deficient in mitochondria (Fig. 1) . Demonstrating the protocol's effectiveness, mitochondriadepleted cells showed no detectable mitochondrial respiration, proteins or mtDNA, and, strikingly, no mitochondrial organelles were observed by 3D electron microscopy 15, 16 . After mitochondrial depletion, cells fail to repopulate their mitochondrial population over extended periods of time (16 d post removal of carbonyl cyanide 3-chlorophenylhydrazone (CCCP)), demonstrating effective depletion. Furthermore, we have developed culture conditions to keep mitochondrial-depleted cells in culture, with minimal loss of viability, for long periods of time ranging from 5 d to 1 month (depending on the cell type), allowing extensive longitudinal studies.
Applications of the widespread mitophagy protocol
Investigating the role of mitochondria in cell death. Mitochondria are often essential to the execution of programmed cell death (or apoptosis). The intrinsic pathway of apoptosis is also called 'mitochondrial apoptosis', as the permeabilization of mitochondria is required for caspase activation and cell death 21 . A recently described nonapoptotic type of cell death is necroptosis (programmed necrosis), which requires the executioner protein mixed-lineage kinase domain-like (MLKL; ref. 22) . Mitochondria, through the generation of reactive oxygen species (ROS), were considered to be essential to the execution of necroptosis [23] [24] [25] .
To directly test this, we used Parkin-mediated mitophagy to efficiently remove mitochondria and to assess the technique's effect on necroptosis and apoptosis. As expected, mitochondrial-depleted cells were resistant to mitochondrial apoptosis 15 . However, although Parkin-mediated mitophagy completely prevented ROS production, it did not have an impact on necroptosis execution. This provided the first evidence that mitochondria are dispensable for the execution of necroptosis 15 .
Investigating the role of mitochondria in cellular senescence. Senescence is a cellular response to a variety of stressesincluding oncogene activation, DNA damage and telomere dysfunction-that permanently arrests the cell. Senescence is involved in several processes, including development, cancer and tissue remodeling. Furthermore, increasing evidence suggests that senescence is a major contributor to age-related tissue dysfunction and pathologies, mostly through the development of a pro-oxidant and proinflammatory phenotype 26 . Mitochondrial dysfunction is a feature of senescence 27 and has been shown to induce and stabilize the senescence arrest mostly via the generation of ROS-driven cellular damage 28 . Despite the fact that multiple biochemical reactions occur within the mitochondria, little is known in regard to other factors, apart from ROS, that have an impact on the senescent phenotype. By inducing Parkinmediated widespread mitophagy, our group has demonstrated that mitochondria are required for the development of both the pro-oxidant and proinflammatory senescence-associated phenotypes 16 . This approach demonstrated the requirement of mitochondria for the development of several features of the senescent phenotype that are considered drivers of the aging process, suggesting these organelles as putative therapeutic targets for interventions aimed at inhibiting senescence and aging.
Mitophagy as a readout of autophagic flux. Autophagy is a recycling process delivering various cytosolic cargoes (including whole organelles such as mitochondria or peroxisomes) to lysosomes for degradation. Autophagy has lately received considerable attention because of its involvement in a multitude of human diseases, ranging from neurodegenerative disorders to cancer 29, 30 . It is therefore important to develop reliable methods of assessing autophagic flux in vitro. This is especially relevant when testing new autophagy inhibitors that could be translated into clinical trials. The most commonly used method of characterizing autophagy is western blotting or immunofluorescence detection of lipidated LC3 (or LC3-II), which is indicative of autophagosome assembly. Nevertheless, inhibition of autophagosome breakdown and stimulation of autophagy can both increase LC3-II levels, thereby complicating analysis. As such, a quantitative measure of autophagic flux is a greatly preferred measure. To address this issue, our laboratory has recently used the Parkin-mediated mitophagy protocol as a readout of autophagic flux 31 . Briefly, mitophagy was used to detect differences in the autophagic flux between various cell lines with accurate detection and characterization of the effect of pharmacological or genetic inhibition/promotion of autophagy 31 . 
Advantages, limitations and adaptations
Traditional methods of perturbing mitochondrial function have relied on the deletion of mtDNA, typically through long-term EtBr treatment 17 . Nevertheless, although this effectively depletes mtDNA, the mitochondria themselves remain in the cell, and many of their associated functions persist. Moreover, it takes a considerable amount of time to achieve mtDNA depletion (weeks to months), and EtBr may exert unwanted effects upon nuclear DNA. The protocol described below, using Parkin-mediated mitochondrial depletion, addresses these issues by completely removing mitochondria in a quick (24-48 h) and specific manner. Furthermore, this approach enables the generation of cell populations that show high penetrance of mitochondrial depletion (>95% of cells with no detectable mitochondria) and therefore greatly facilitates the study of mitochondria in various cellular processes. Potential limitations of this assay are that some cells do not readily survive mitochondrial depletion. In our experience, all cell lines that we have used show minimal cytotoxicity in reponse to short-term CCCP or antimycin A and oligomycin A (A/O) treatment. However, activation of Parkin-mediated mitophagy can cause extensive caspase-dependent apoptosis in some cell lines (HeLa, for example). For unclear reasons, this cytoxicity appears to be cell-type-dependent, but nevertheless it can be prevented by the coapplication of caspase inhibitors. Second, the use of chemicals such as CCCP to induce mitophagy can have unwanted off-target effects 32 . In addition, effective mitochondrial depletion requires ectopic expression of Parkin, which may exert unwanted effects on the biological process being investigated. An approach involving the use of an inducible Parkin expression vector, such that Parkin expression is switched off post mitophagy, may circumvent this limitation. Finally, although the transduction of immortalized cells is often highly efficient, generation of stable cell lines using primary cells can be more troublesome; below we describe a protocol for both immortalized and primary cell lines.
Experimental design
The protocol can be divided into three main parts: generation of a stable YFP-Parkin-expressing cell line (Steps 1-15); induction of widespread mitophagy (Steps [16] [17] [18] [19] [20] ; and long-term culture of mitochondria-depleted cells (Steps 21-24). We finish with a brief summary for readouts of widespread mitophagy (Box 1).
Generation of a stable YFP-Parkin-expressing cell line. In this protocol, we describe how to generate a stable YFP-Parkinexpressing cell line in primary human fibroblasts. Nevertheless, similar procedures have been successfully tested in other human primary (e.g., IMR-90) and immortalized cells (e.g., KP-4 and HeLa cells) and murine cells (e.g., SVEC and 3T3 cells). We also describe cell culture conditions in which primary fibroblasts can be viably maintained for up to a month following mitochondrial depletion, allowing for kinetics assays and long-term studies.
In this protocol, we use Phoenix amphotropic cells to produce retroviral particles. Phoenix amphotropic packaging cell lines are second-generation retrovirus producer lines that were generated from human embryonic kidney (HEK) 293T cells 33, 34 . In addition to the temperature-sensitive T antigen coselected with neomycin that is already present in HEK293T cells, Phoenix amphotropic cells contain two extra constructs: a construct capable of producing the gag-pol construct and a construct for the codification of the envelope protein for amphotropic viruses. The gag-pol and the envelope protein sequences were introduced with hygromycin and diphtheria toxin resistance, respectively, as the coselectable markers. The expression of each construct is under the regulation of different non-Moloney promoters to minimize recombination potential. The incorporation of these constructs into the Phoenix cells makes the transfection process relatively easy: packaging cells (Phoenix amphotropic cells), retroviral vectors and the transfection reagent are the only required transfection components (no requirement for additional packaging constructs). This cell line is highly transfectable with either calcium-phosphate-mediated transfection or lipid-based transfection protocols, with ≥50% cells being transiently transfected. In this protocol, we use and describe a lipid-based transfection protocol using Lipofectamine.
Next, we describe a protocol for the transduction of primary human fibroblasts with YFP-Parkin retroviral particles.
Box 1 | Readouts of widespread mitophagy • tIMInG 2-3 d
We suggest the following conventional methods for determination of widespread mitophagy: western blotting (Fig. 2a,g ); immunofluorescence staining for specific mitochondrial proteins, followed by microscopy and/or flow cytometry analysis ( Fig. 2b-d) ; and qPCR for mtDNA copy number (Fig. 2e) . Antibodies used for western blotting and immmunofluorescence, and primers for mtDNA copy number assays are described in the MATERIALS section.
Furthermore, we can detect clearance of mitochondria by live-cell imaging of YFP-Parkin cells expressing a mitochondrial-targeted protein (for instance mito-dsRed; supplementary Video 1). Briefly, for live-cell imaging, plate YFP-Parkin-expressing cells transiently expressing mitochondrial-targeted dsRed (mito-dsRed) on 35-mm glass-bottom dishes and image using a long-term time-lapse Nikon TE2000 microscope. Before imaging, treat cells with A/O, using the protocol described above. Human diploid fibroblasts, such as MRC5 fibroblasts, undergo a finite number of cell divisions or population doublings (PDs) before permanently arresting in the cell cycle in a state termed 'replicative senescence' 35 . Therefore, following a precise protocol when culturing and generating stable primary human fibroblast cell lines is essential. For this reason, calculating the PD rate of human primary fibroblasts is required to evaluate the number of cell divisions that these cells have undergone and to avoid transducing cells that are reaching their proliferative limit. Human fibroblasts are also sensitive to cell confluency: underconfluency (≤40% cell density) or overconfluency (≥100% cell density) can induce cellular stress and lead to premature senescence. It is thus necessary to calculate cell density for optimized cell fitness, transduction and posterior selection with antibiotics (e.g., Zeocin).
Induction of widespread mitophagy. In this protocol, widespread mitophagy is achieved by inducing overall mitochondrial depolarization. CCCP is a protonophore (H + ionophore) and uncoupler of oxidative phosphorylation in mitochondria that promotes loss of mitochondrial membrane potential (∆Ψ m ) and morphological swelling 36 . Treatment of YFP-Parkin-expressing cells with CCCP ensures mitochondrial dysfunction and translocation of Parkin to the mitochondria, where it binds to PINK1 that has accumulated in the outer mitochondrial membrane (Fig. 1) . An alternative to CCCP-that can show off-target effects on lysosomal function 32 -is a mix of A/O (in equimolar amounts); A/O are specific mitochondrial uncouplers. Typically, the widespread mitophagy protocol takes 48 h. Although immortalized cells require treatment with the mitochondrial membrane uncoupler every 12 h, primary cells require treatment only every 24 h, for 48 h. Note that the mitochondrial uncoupler dose and treatment duration should be tested for each cell line in order to efficiently induce widespread mitochondrial depletion.
Long-term culture of mitochondria-depleted cells. In the procedure, we describe the culture conditions that allow long-term culturing of cells depleted of mitochondria. This is mainly achieved by supplementing the growth medium with uridine (Urd).
Assessment of mitophagy.
The effectiveness of induced mitophagy can be assessed in multiple ways, but it typically relies upon detecting the loss of mitochondrial protein(s) signal or loss of mtDNA. Importantly, Parkin has been shown to target some mitochondrial proteins for proteasomal degradation independently of mitophagy 37, 38 . Therefore, multiple approaches should be used, at least in initial experiments, to verify that the method is functional.
MaterIals
REAGENTS  crItIcal The indicated reagents or suppliers listed below can be substituted with appropriate alternatives if necessary.
Cell culture
Cell lines: the generation of a YFP-Parkin-expressing cell line involves the culturing of a packaging cell line for YFP-Parkin retroviral production, in this case Phoenix amphotropic cells, and a cell line that will be subjected to YFP-Parkin retroviral transduction and become the YFP-Parkin-expressing cell line (see Table 1 
YFP-Parkin vector transfection and retroviral transduction
pLZRS-empty vector (gift from G.P. Nolan, Stanford University) Antibodies: detection of mitochondrial proteins using western blotting and/or immunofluorescence staining can be performed using conventional protocols and reagents 15 . In Table 2 , we describe the antibodies used for mitochondrial protein detection in this protocol Primers for qPCR analysis: detection of mtDNA is performed by qPCR.
In Table 3 we describe the mtDNA and nuclear (control) primers (Sigma-Aldrich) for mtDNA analysis used in this protocol 15 ) FBS, 100 units per ml penicillin, 100 µg/ml streptomycin, 2 mM glutamine, 1 mM sodium pyruvate, 300 µg/ml hygromycin B and 1 µg/ml diphtheria toxin. This medium can be stored at 4 °C for up to 1 month. Culture medium for human MRC5 fibroblasts Supplement DMEM medium with 10% (vol/vol) FBS, 100 units per ml penicillin, 100 µg/ml streptomycin and 2 mM glutamine. This medium can be stored at 4 °C for up to 1 month. Culture medium for human MRC5 fibroblasts without mitochondria Supplement DMEM medium with 10% (vol/vol) FBS, 100 units per ml penicillin, 100 µg/ml streptomycin, 2 mM glutamine and 50 µg/ml Urd. This medium can be stored at 4 °C for up to 1 month. Incubate the cells at 37 °C overnight in a humidified 5% CO 2 incubator.  crItIcal step Primary human fibroblasts do not form colonies when proliferating, and therefore they do not allow for viral titering, which permits optimization of viral transduction volumes for efficient transductions. Furthermore, efficiency of transfection and viral particle generation can vary from experiment to experiment and with the size of the plasmid DNA. We advise performing transduction with several viral supernatant volumes; for example, seed three wells in a six-well plate for the following: (i) 1-ml viral transduction; (ii) 2-ml viral transduction and (iii) nontransduced control (mock).  crItIcal step When using human primary cells, use cells at a lower PD in order to avoid producing a cell line that by the end of the transduction process is senescent or is approaching senescence. To calculate the PD, cells should be trypsinized and counted in order to calculate the total number of cells. The following formula should then be applied: PD = x ± (Ln(n2/n1)/Ln2, where x is the number of the accumulated PD, n2 is the total number of cells obtained and n1 is the number of cells initially seeded in the plate.
EQUIPMENT

9| Day 5.
Forty-eight hours post transfection, collect virus-containing supernatants into a 15-ml sterile, capped, conical tube. Collection of virus-containing supernatants can also be done 72 h post transfection, with negligible differences in viral yield observed regardless of whether viral collection is performed at 48 or 72 h post transfection.
10|
Collect and centrifuge the supernatants containing the viruses for 15 min at 1,600g (4 °C), followed by supernatant filtration using a Millex-HV 0.45-µm or equivalent PVDF filter. This prevents packaging cells (retroviral producers) from contaminating the cell line to be transduced.
11|
Add the purified medium with 10 µg/ml polybrene to cells at 50-60% cell confluency from Step 8. Incubate the mixture at 37 °C overnight in a humidified 5% CO 2 incubator.  crItIcal step Note that this step should be performed immediately after Step 10. Alternatively, viral particles can be frozen at −80 °C after collection and purification (note that in some cases transduction efficiency can be affected if you are using viral particles that were previously frozen; avoid freeze-thaw cycles). ? troublesHootInG 12| Day 6. Remove the medium containing viral particles and add 2 ml per well of complete culture medium. Incubate the mixture at 37 °C overnight in a humidified 5% CO 2 incubator.
13| Day 7.
Remove the medium and wash the cells once with PBS. Trypsinize the cells and replate all cells (each well of a six-well plate) in one 10-cm plate containing complete culture medium. Incubate at 37 °C overnight in a humidified 5% CO 2 incubator. 
14|
Induction of widespread mitophagy • tIMInG 4-6 d
 crItIcal In this section, we describe general conditions for the induction of widespread mitophagy in primary cells. Despite following a similar protocol, culture of primary and immortalized cells can differ in a few aspects of the protocol; below we describe the details regarding these differences.  crItIcal Cell density before and during induction of widespread mitophagy can have an impact on the success of the protocol. 16| Day 21. Seed 1.5 × 10 6 YFP-Parkin-expressing human primary fibroblasts from Step 15 (e.g., MRC5 or IMR90 cells; 20 < PD < 25) in 10-cm culture dishes in 10 ml of complete culture medium. Incubate the cells at 37 °C overnight in a humidified 5% CO 2 incubator.  crItIcal step Cells should be 70% confluent the next day. The number of cells seeded is dependent on the PD value; with advancing PD values, cells start to become bigger (pre-senescent), which affects cell culture density (e.g., lower-PD cells must be seeded at higher density). It is therefore critical to adjust the number of cells to the PD value.  crItIcal step Other cell lines, particularly immortalized cell lines, may require different cell culture densities when applying this protocol (e.g., HeLa cells should be at 10-20% confluency before induction of mitophagy, for optimal efficiency of the protocol). 
17|
long-term culture of mitochondria-depleted cells • tIMInG 4-30 d
 crItIcal The absence of mitochondria will affect the function of the mitochondrial enzyme dihydroorotate dehydrogenase, which is involved in pyrimidine synthesis 17 . One way to overcome this is through the addition of Urd to the cell culture medium. We have found that primary fibroblasts positively respond to the addition of Urd to the cell culture medium, allowing viability in culture for longer periods of time. Below, we describe how to culture mitochondria-depleted primary cells for a long period (up to 15 d in proliferating cells and up to 30 d in permanently arrested (senescent) cells). 21| Day 25. Seed 1.5 × 10 6 human primary fibroblasts (20 < PD < 25) in a 10-cm dish in complete medium and allow the cells to adhere at 37 °C overnight in a humidified 5% CO 2 incubator. Cells should be 70-90% confluent the next day. At the same time, seed cells for mitochondria-depletion QC assays, as described in Step 17.  crItIcal step It is critical that cells be 70-90% confluent before treatment with the mitochondria uncoupler. Cell density will depend on the duration of the experiment: the longer the experiment, the higher the cell density required before treatment, as mitochondria-depleted cells tend to become smaller with time, compromising optimal cell density/contact and viability.
22| Days 26 and 27.
Treat cells every 24 h, over a 48-h period, with 12.5 µM CCCP in complete medium. Cells can also be treated with 1 µM antimycin A and 1 µM oligomycin A in complete culture medium.  crItIcal step CCCP and A/O are not stable in the medium for longer periods of time and therefore need to be refreshed at least every 24 h. The drug refreshment periods may need to be adjusted for different primary cells.
23| Day 28.
Remove the medium containing CCCP and replace it with complete medium with an additional 50 µg/ml of Urd. Incubate the cells at 37 °C in a humidified 5% CO 2 incubator. At this point, the cells should be devoid of mitochondria; collect cells for mitochondria-depletion QC assays, as described in Step 19. Primary fibroblasts require 70-90% cell density, before and during treatment, for optimal cell viability post treatment. However, other cells lines, particularly immortalized lines (e.g., HeLa cells), require lower cell confluency using this protocol. Determining the optimal cell density for the cell line of interest is critical to the success of the protocol For the cell lines described in this protocol, 12.5 µM CCCP is the optimal dose promoting complete mitophagy, with minimal cell toxicity or off-target effects. However, if using cell lines different from the ones described in this protocol, perform a CCCPconcentration-dependent survival curve and determine the optimal drug dose and treatment duration/ periodicity. 
antIcIpateD results
In Figure 2 , we show different experiments that confirm the complete removal of mitochondria using the widespread mitophagy protocol. In Figure 2a , KP-4 YFP-Parkin cells were treated with A/O for 48 h and then immunoblotted with Mitoprofile. In Figure 2b ,c, the same cells were immunostained for COXIV and TIMM44, and no mitochondria were observed. In Figure 2d , we confirm mitochondrial depletion by using FACS for the same proteins as in Figure 2b ,c. In Figure 2e , we observed negligible levels of mtDNA in KP-4 YFP-Parkin cells upon induction of mitophagy with A/O for 48 h. In Figure 2f , we illustrate the procedure for clearance of mitochondria followed by long-term culture of cells (applicable only to human primary fibroblasts). In Figure 2g , we show expected western blotting results for several mitochondrial proteins-NDUFB8, SDHA, UQCRC2 and TOMM20-at days 4 and 16 after removal of CCCP. These results demonstrate that the initial CCCP treatment is sufficient for clearance of mitochondria and no repopulation occurs at later stages. 
